HomeAI · summaries
Storia in 5 fonti
India hikes cancer drug prices by 50% amid shortages
India's NPPA approved a 50% price hike for carboplatin and cisplatin, citing rising platinum costs, to address accessibility concerns for these critical anti-cancer medicines.
Confronto fonti
5 prospettive sulla stessa storiaTimeline cronologica
- ·
economictimes.indiatimes.com
Indian cancer patients battle shortage of key drugs as platinum costs surge
Cancer patients in India are struggling to find essential platinum-based drugs. A surge in global platinum prices and supply chain issues are causing shortages. This forces…
- ·
nu.nl
Indiase kankerpatiënten kampen met tekort medicijnen door prijsstijging platina
Kankerpatiënten in India hebben grote moeite essentiële geneesmiddelen op basis van platina te vinden. Dat komt door problemen met levering en de sterk gestegen prijzen. Sommige…
